These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6621949)

  • 1. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.
    Notelovitz M; Kitchens C; Ware M; Hirschberg K; Coone L
    Obstet Gynecol; 1983 Nov; 62(5):596-600. PubMed ID: 6621949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women.
    Callejon DR; Franceschini SA; Montes MB; Toloi MR
    Maturitas; 2005; 52(3-4):249-55. PubMed ID: 16257613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
    Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH; Krämer R; Kwee B; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR; Skouby SO; Sidelmann J; Jespersen J
    Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hormonal contraceptives on the coagulation system with special reference to its inhibitors].
    Misz M; Beck P; Flóra-Nagy M
    Orv Hetil; 1985 Oct; 126(43):2635-40. PubMed ID: 4058912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
    Hemelaar M; Kenemans P; Hack CE; Klipping C; van der Mooren MJ
    Menopause; 2008; 15(2):248-55. PubMed ID: 17693902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of antithrombin III on anticoagulating system function in animals intravenously injected with tissue thromboplastin].
    Pastorova VE; Kovalev SV
    Vopr Med Khim; 1976; 22(2):240-5. PubMed ID: 1025886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
    Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.